157 related articles for article (PubMed ID: 23237571)
1. Therapeutic effect of c-Jun N-terminal kinase inhibition on pancreatic cancer.
Takahashi R; Hirata Y; Sakitani K; Nakata W; Kinoshita H; Hayakawa Y; Nakagawa H; Sakamoto K; Hikiba Y; Ijichi H; Moses HL; Maeda S; Koike K
Cancer Sci; 2013 Mar; 104(3):337-44. PubMed ID: 23237571
[TBL] [Abstract][Full Text] [Related]
2. c-Jun N-terminal kinase in pancreatic tumor stroma augments tumor development in mice.
Sato T; Shibata W; Hikiba Y; Kaneta Y; Suzuki N; Ihara S; Ishii Y; Sue S; Kameta E; Sugimori M; Yamada H; Kaneko H; Sasaki T; Ishii T; Tamura T; Kondo M; Maeda S
Cancer Sci; 2017 Nov; 108(11):2156-2165. PubMed ID: 28837246
[TBL] [Abstract][Full Text] [Related]
3. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
[TBL] [Abstract][Full Text] [Related]
4. Dual c-Jun N-terminal kinase-cyclin D1 and extracellular signal-related kinase-c-Jun disjunction in human melanoma.
Pathria G; Garg B; Garg K; Wagner C; Wagner SN
Br J Dermatol; 2016 Dec; 175(6):1221-1231. PubMed ID: 27145925
[TBL] [Abstract][Full Text] [Related]
5. JNK pathway inhibition selectively primes pancreatic cancer stem cells to TRAIL-induced apoptosis without affecting the physiology of normal tissue resident stem cells.
Recio-Boiles A; Ilmer M; Rhea PR; Kettlun C; Heinemann ML; Ruetering J; Vykoukal J; Alt E
Oncotarget; 2016 Mar; 7(9):9890-906. PubMed ID: 26840266
[TBL] [Abstract][Full Text] [Related]
6. c-Jun N-terminal kinase inhibitor SP600125 enhances barrier function and elongation of human pancreatic cancer cell line HPAC in a Ca-switch model.
Konno T; Ninomiya T; Kohno T; Kikuchi S; Sawada N; Kojima T
Histochem Cell Biol; 2015 May; 143(5):471-9. PubMed ID: 25511417
[TBL] [Abstract][Full Text] [Related]
7. Novel participation of transglutaminase-2 through c-Jun N-terminal kinase activation in sphingosylphosphorylcholine-induced keratin reorganization of PANC-1 cells.
Park MK; Lee HJ; Shin J; Noh M; Kim SY; Lee CH
Biochim Biophys Acta; 2011 Dec; 1811(12):1021-9. PubMed ID: 21840417
[TBL] [Abstract][Full Text] [Related]
8. Endogenous c-Jun N-terminal kinase (JNK) activity marks the boundary between normal and malignant granulosa cells.
Bildik G; Akin N; Senbabaoglu F; Esmalian Y; Sahin GN; Urman D; Karahuseyinoglu S; Ince U; Palaoglu E; Taskiran C; Arvas M; Guzel Y; Yakin K; Oktem O
Cell Death Dis; 2018 Apr; 9(4):421. PubMed ID: 29549247
[TBL] [Abstract][Full Text] [Related]
9. Treatment of 13-cis retinoic acid and 1,25-dihydroxyvitamin D3 inhibits TNF-alpha-mediated expression of MMP-9 protein and cell invasion through the suppression of JNK pathway and microRNA 221 in human pancreatic adenocarcinoma cancer cells.
Cheng YH; Chiang EI; Syu JN; Chao CY; Lin HY; Lin CC; Yang MD; Tsai SY; Tang FY
PLoS One; 2021; 16(3):e0247550. PubMed ID: 33730072
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin enhancement of rat pancreatic tumor cell proliferation requires the activation of ERK and JNK signals.
Bose C; Udupa KB
Am J Physiol Cell Physiol; 2008 Aug; 295(2):C394-405. PubMed ID: 18550701
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of glycogen synthase kinase-3 activity triggers an apoptotic response in pancreatic cancer cells through JNK-dependent mechanisms.
Marchand B; Tremblay I; Cagnol S; Boucher MJ
Carcinogenesis; 2012 Mar; 33(3):529-37. PubMed ID: 22201186
[TBL] [Abstract][Full Text] [Related]
12. Basal c-Jun NH2-terminal protein kinase activity is essential for survival and proliferation of T-cell acute lymphoblastic leukemia cells.
Cui J; Wang Q; Wang J; Lv M; Zhu N; Li Y; Feng J; Shen B; Zhang J
Mol Cancer Ther; 2009 Dec; 8(12):3214-22. PubMed ID: 19996270
[TBL] [Abstract][Full Text] [Related]
13. GNAS(R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm.
Taki K; Ohmuraya M; Tanji E; Komatsu H; Hashimoto D; Semba K; Araki K; Kawaguchi Y; Baba H; Furukawa T
Oncogene; 2016 May; 35(18):2407-12. PubMed ID: 26257060
[TBL] [Abstract][Full Text] [Related]
14. A c-Jun NH2-terminal kinase inhibitor SP600125 (anthra[1,9-cd]pyrazole-6 (2H)-one) blocks activation of pancreatic stellate cells.
Masamune A; Kikuta K; Suzuki N; Satoh M; Satoh K; Shimosegawa T
J Pharmacol Exp Ther; 2004 Aug; 310(2):520-7. PubMed ID: 15056726
[TBL] [Abstract][Full Text] [Related]
15. p8 inhibits the growth of human pancreatic cancer cells and its expression is induced through pathways involved in growth inhibition and repressed by factors promoting cell growth.
Malicet C; Lesavre N; Vasseur S; Iovanna JL
Mol Cancer; 2003 Nov; 2():37. PubMed ID: 14613582
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of tumor growth, angiogenesis, and tumor cell proliferation by a small molecule inhibitor of c-Jun N-terminal kinase.
Ennis BW; Fultz KE; Smith KA; Westwick JK; Zhu D; Boluro-Ajayi M; Bilter GK; Stein B
J Pharmacol Exp Ther; 2005 Apr; 313(1):325-32. PubMed ID: 15626722
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Jun NH2-terminal kinases suppresses the growth of experimental head and neck squamous cell carcinoma.
Gross ND; Boyle JO; Du B; Kekatpure VD; Lantowski A; Thaler HT; Weksler BB; Subbaramaiah K; Dannenberg AJ
Clin Cancer Res; 2007 Oct; 13(19):5910-7. PubMed ID: 17908987
[TBL] [Abstract][Full Text] [Related]
18. Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation.
Park MK; You HJ; Lee HJ; Kang JH; Oh SH; Kim SY; Lee CH
Eur J Cancer; 2013 May; 49(7):1692-705. PubMed ID: 23290789
[TBL] [Abstract][Full Text] [Related]
19. Dominant negative MEKK1 inhibits survival of pancreatic cancer cells.
Hirano T; Shino Y; Saito T; Komoda F; Okutomi Y; Takeda A; Ishihara T; Yamaguchi T; Saisho H; Shirasawa H
Oncogene; 2002 Aug; 21(38):5923-8. PubMed ID: 12185592
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity: evidence that mitotic Bcl-2 phosphorylation is JNK-independent.
Du L; Lyle CS; Obey TB; Gaarde WA; Muir JA; Bennett BL; Chambers TC
J Biol Chem; 2004 Mar; 279(12):11957-66. PubMed ID: 14704147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
